115 related articles for article (PubMed ID: 107356)
41. [Serious complications following topical administration of thio-tepa in a patient with bladder carcinoma].
Kaczmarek A
Wiad Lek; 1978 Apr; 31(8):547-50. PubMed ID: 96607
[No Abstract] [Full Text] [Related]
42. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
Sakuragawa N
Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
[No Abstract] [Full Text] [Related]
43. [A case of arterial thrombosis successfully treated with a large dosage of urokinase--study on urokinase administration with special reference to alpha2-plasmin inhibitor (author's transl)].
Hayashi S; Yamada K
Rinsho Ketsueki; 1979 Apr; 20(4):400-9. PubMed ID: 156270
[No Abstract] [Full Text] [Related]
44. Comparative study of different urokinase preparations.
Millar WT; Smith JF
Thromb Res; 1983 Jun; 30(5):425-9. PubMed ID: 6351343
[TBL] [Abstract][Full Text] [Related]
45. Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.
Edsmyr F; Boman J
Acta Radiol Ther Phys Biol; 1970 Oct; 9(5):395-400. PubMed ID: 4990891
[No Abstract] [Full Text] [Related]
46. [Experimental studies on the mode and amount of urokinase administration in thrombolytic therapy (author's transl)].
Matsuo O; Mihara H
Rinsho Ketsueki; 1977 Sep; 18(9):1097-101. PubMed ID: 592505
[No Abstract] [Full Text] [Related]
47. The plasminogen activator and esterase activities of the two forms of urokinase.
Ong EB; Soberano ME; Johnson AJ; Dharmgrongartama ED
Thromb Res; 1981 Nov; 24(3):223-32. PubMed ID: 7038974
[No Abstract] [Full Text] [Related]
48. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
Horn Y; Eidelman A; Walach N; Ilian M
J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
[No Abstract] [Full Text] [Related]
49. Single and sequential combination intravesical chemotherapy of murine bladder cancer.
Soloway MS; Nissenkorn I; McCallum LW; Murphy WM
Urology; 1982 Feb; 19(2):169-75. PubMed ID: 6800090
[TBL] [Abstract][Full Text] [Related]
50. The morphologic effects of mitomycin C in mammalian urinary bladder.
Murphy WM; Soloway MS; Crabtree WN
Cancer; 1981 Jun; 47(11):2567-74. PubMed ID: 6790156
[TBL] [Abstract][Full Text] [Related]
51. [Dibunol and thio-TEPA treatment of bladder tumors].
Barsel' VA
Urol Nefrol (Mosk); 1978; (4):27-30. PubMed ID: 98889
[No Abstract] [Full Text] [Related]
52. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
[TBL] [Abstract][Full Text] [Related]
53. [Studies on coagulation and fibrinolysis. III. Urokinase activated fibrinolysodynamicogram].
Hu YM; Xue H; Wang KQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Jun; 4(3):133-6. PubMed ID: 6215134
[No Abstract] [Full Text] [Related]
54. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes.
Dahl R; Venge P
Thromb Res; 1979; 14(4-5):599-608. PubMed ID: 483258
[No Abstract] [Full Text] [Related]
55. [Various aspects of the platelets-urokinase interaction].
Bastida E; Villaverde CA; Borruel MT; Valdecasas FG
Arch Farmacol Toxicol; 1979 Dec; 5(3):270-1. PubMed ID: 397805
[No Abstract] [Full Text] [Related]
56. [In vitro measurement of fibrinolysis by urokinase].
Senf L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):819-21. PubMed ID: 6176506
[TBL] [Abstract][Full Text] [Related]
57. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
Takada A; Takada Y
Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
[No Abstract] [Full Text] [Related]
58. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
59. The modifying effect of hexavalent chromate on the mutagenic activity of thio-TEPA.
Paschin YV; Kozachenko VI
Mutat Res; 1982 Mar; 103(3-6):367-70. PubMed ID: 6806645
[No Abstract] [Full Text] [Related]
60. [Evaluation and importance of the clot-promoting potential of urokinase].
Morito T; Kuto M; Wada H; Urata T; Lee CJ; Deguchi K; Shirakawa S
Nihon Ketsueki Gakkai Zasshi; 1983 May; 46(3):759-66. PubMed ID: 6351526
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
